Holen Sie sich die Stockscreener-App
207.91
1.27%
-2.67
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$210.58
Offen:
$211.99
24-Stunden-Volumen:
1.39M
Relative Volume:
1.65
Marktkapitalisierung:
$13.34B
Einnahmen:
$13.84B
Nettoeinkommen (Verlust:
$1.10B
KGV:
19.96
EPS:
10.4185
Netto-Cashflow:
$1.49B
1W Leistung:
+2.00%
1M Leistung:
+4.21%
6M Leistung:
+79.00%
1J Leistung:
+53.11%
1-Tages-Spanne:
$206.85
$213.07
1-Wochen-Bereich:
$204.06
$213.44
52-Wochen-Spanne:
$101.00
$213.44
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
207.91 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
375.17 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
172.57 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
98.03 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Why DaVita® In-Center Nocturnal Dialysis quietly changes patients’ nights - AD HOC NEWS
DaVita StockWeekly review and sector backdrop without fresh headlines - AD HOC NEWS
How DaVita’s New $500 Million Term Loan and Higher Guidance Will Impact DaVita (DVA) Investors - simplywall.st
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. SharesInsider sale and technical picture on Thursday - AD HOC NEWS
DaVita Inc (DVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Why DaVita Care Connect quietly changes dialysis days - AD HOC NEWS
DaVita stock gains from integrated kidney care and CKCC progress - MSN
DaVita Inc (DVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
DaVita Inc (DVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DaVita Inc (DVA) CEO Javier Rodriguez Sells 69,407 Shares - GuruFocus
DaVita legal chief K. Waters sells $3.2m in stock By Investing.com - Investing.com South Africa
DaVita(DVA.US) Officer Sells US$14.53 Million in Common Stock - Moomoo
DaVita Insiders Sold Shares Worth Over $17M - TradingView
DaVita legal chief K. Waters sells $3.2m in stock - Investing.com
DaVita Expands Specialized Care Beyond Acute Settings Through IKC - Zacks Investment Research
DaVita Inc (DVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DaVita Inc (DVA) Institutional Confidence - TradingKey
DaVita Inc (DVA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DaVita Inc (DVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DaVita Inc (DVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DaVita Stock Surges 9.2%, With A 5-Day Winning Spree - Trefis
5-Day Rally Sends DaVita Stock Up 9.2% - Trefis
Expanded access, DaVita Patient-Facing Mobile App enters next phase of kidney care - AD HOC NEWS
DaVita vs. Encompass Health: Comparing Steady Patient Volumes and Growth RatesNews and Statistics - IndexBox
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
DaVita Inc. Stock (US23918K1088): Stock in focus after chart signals and a long-term return snapshot - AD HOC NEWS
DaVita gains 21.4% in three months: How should you play the stock? - MSN
DaVita Inc. Stock (US23918K1088): Valuation picture draws attention after recent gains - AD HOC NEWS
DaVita expands comprehensive kidney care through dialysis services - MSN
DaVita (DVA) Stock After 82% YTD Surge Is The Price Still Justified - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc (DVA) News, Articles, Events & Latest Updates - Stocktwits
DaVita Inc. Stock (US23918K1088): valuation metrics in focus for US dialysis provider - AD HOC NEWS
DaVita, SCA, USPI defeat class certification bid in US no-poach litigation - MLex
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress - TradingView
Are Investors Undervaluing DaVita (DVA) Right Now? - Yahoo Finance
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare - Yahoo Finance
DaVita’s US$500 Million Term Loan Reshapes Debt And Liquidity Profile - Yahoo Finance
DaVita Inc. $DVA Stake Lifted by Los Angeles Capital Management LLC - MarketBeat
A Look at DaVita Inc (DVA) After 3.2% Gain -- GF Value $172.98 v - GuruFocus
DaVita Expands Term Loan Facility, Enhancing Capital Flexibility - The Globe and Mail
Best Growth Stocks to Buy for June 9th - Yahoo! Finance Canada
Best Value Stocks to Buy for June 9th - Yahoo Finance Singapore
DaVita Inc. (DVA) Announces Ninth Amendment to Credit Agreement - GuruFocus
DavitaEnters Ninth Amendment To Credit Agreement With Jpmorgan On June 8, 2026SEC Filing - TradingView
DaVita Secures $500 Million Incremental Term Loan B-2 Under Credit Facility With JPMorgan - TradingView
DaVita Inc. Enters into Ninth Amendment to Credit Agreement for $500 Million Incremental Tranche B-2 Term Loan - marketscreener.com
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.08%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):